Direct Human Cartilage Repair Using Three-Dimensional Bioprinting Technology

630 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Bioprinting Toward Organ Fabrication: Challenges and Future Trends (2013, methodology): “Cui and his coworkers [17] applied inkjet printing technol-”
A comprehensive review on droplet-based bioprinting: Past, present and future. (2016, background): “On the other hand, achievements in regenerative medicine include tissue transplants [35,92] and in-situ bioprinting [56] for improved wound healing.”
3D Bioprinting for Engineering Complex Tissues (2015, background): “…cost due to similar structure with commercial printers, (2) high printing speed conferred by the ability of the printer heads to support parallel work mode, and (3) relatively high cell viability (usually from 80% to 90%), as determined by many experimental results (Cui et al., 2012a, 2012b, 2013).”
Recent advances in 3D printing of biomaterials (2015, neutral): “Cell encapsulation during SLA has been shown with PEG-DA with NIH/3T3 cells [81] and PEG-DMA with human chondrocytes although with an inkjet printer [82].”
Current Status of Bioinks for Micro-Extrusion-Based 3D Bioprinting (2016, background): “This makes PEG versatile and it can be tailored to form a crosslinked system with PEG as the main backbone [66] or even using PEG as a crosslinker for other systems, as shown in Figure 5 [89].”